Elmiron Litigation
If you are reading these words, then it’s quite possible that you took the drug Elmiron for Interstitial Cystitis (IC), also referred to as painful bladder syndrome. After taking Elmiron for a year or more, you may have been diagnosed with any number of degenerative eye conditions, as unrelated as that might sound.
However, several studies have brought the link between taking Elmiron and failing eyesight into focus.
If the above scenario describes something similar to what you’ve experienced, then Junell & Associates would like to speak with you. There are legal options that we can help you visualize into reality, but we can’t help you unless we speak with you. If you’d like to start seeing a clear legal path toward compensation after being injured from Elmiron, then please fill out the form on this page, OR call us at 713-221-3750 M – F, 9 – 5 PM Central.
What is the Elmiron Litigation?
All potential Elmiron lawsuits are currently being considered on the grounds that Janssen Pharmaceuticals was negligent in properly warning patients and doctors of known eye-related injury risks. As such, consumers were not able to make informed decisions for their healthcare and avoid injuries.
As stated above, studies have shown a link between Elmiron and progressive retinal damage diagnosed as one of the following:
- Pigmentary Maculopathy (the signature injury—generally, this is gradual loss of central vision characterized by a dark spot when looking straight ahead)
- Maculopathy
- Degenerative maculopathy / macular degeneration
- Macular retinopathy
- Macular / pattern dystrophy
- Retinopathy
- Retinal pigment epithelium atrophy
- Vision loss
- Vision impairment
- Scotoma (area of loss of vision or blind spot)
- Halo vision
- Unilateral blindness (in one eye)
- Bilateral blindness (in both eyes)
- Blurred vision
- Metamorphopsia (distortion of linear objects or lines such that they appear curved)
- Reduced night vision
Simply put, if you were prescribed Elmiron and then got diagnosed with one of the eye conditions listed above, then we’d like to help shine a light on your legal options against Janssen Pharmaceuticals. To be clear, these claims would not be against your medical provider; it’s believed that Jannsen Pharmaceuticals—the manufacturer of Elmiron—knew of the eye-related risks without properly warning providers before the drug made its way to you. That is particularly egregious since Elmiron is the only FDA-approved pill to treat IC.
More About Elmiron and Interstitial Cystitis (IC)
- More than 1,000,000 people in the U.S. have Interstitial Cystitis (IC), 90% of them women
- Elmiron is the only FDA-approved pill to treat IC— there are no generics
- As a mainstay of treatment for IC for decades, hundreds of thousands of people have taken Elmiron
- It’s estimated that at least 11% of Elmiron users have experienced some form of retinal damage, and one study shows it could be as high as 20%
What Should You Do?
Call us. Or fill out the form on this page so that we can contact you. It’s free to discuss your options, and you should. Plaintiffs that took Elmiron are filing lawsuits across the country, and if that’s the right course of action for you, then we’ll absolutely take that journey together. But every client is different, and what’s right for someone else might not be right for you. Still, we’ll need to discuss your particular facts before being able to make a determination either way. Making the connection between Elmiron and something like Pigmentary Maculopathy isn’t always clear, and for that you’ll need specialized attention.
We have helped tens of thousands of people receive over $1 billion in compensation for their injuries. Our clients see why.